AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Prevalence of pretreatment HIV-1 drug resistance among treatment-naïve patients in the Russian Federation, 2014–2018View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Case of detection of drug resistance mutations hepatitis C virus to the direct-acting antiviralsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Genetic characteristic of HIV-1 in patients with treatment failure in Kyrgyzstan in 2017-2018.View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Prevalence and Correlates of Pre-Treatment HIV Drug Resistance among HIV-Infected in the Republic of BelarusView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Late presentation and HIV drug resistance in patients followed in Portugal between 1984-2017View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Antiretroviral resistance in patients with multiple treatment failure in a low-middle income settingView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolatesView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Substantial clustered transmission of the acute hepatitis C among HIV co-infected men-who-have-sex-with-men (MSM)View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Baseline Hepatitis C Virus NS5A Resistance-Associated Polymorphisms in Patients with and without HIV coinfection in MexicoView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Susceptibility to bNAbs of transmitted HIV variants among recent infections in FranceView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Genotyping and treatment issues with unusual 1e and 1g HCV subtypes from African subjects: report of two cases.View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2020Prevalence of transmitted resistance mutations to rilpivirine and doravirine in treatment-naive patients in a large clinical and resistance databaseView Abstract
